-
Several classes of pharmacological agents have demonstrated benefits in hypertensive patients with CAD, but most published studies have, of necessity, enrolled only patients with an elevated or borderline elevated blood pressure. Recent clinical trials have demonstrated benefits for both angiotensin-converting enzyme inhibitors and calcium channel blockers (in patients with coronary artery disease with relatively normal or borderline elevated blood pressures.
-
Although we have recently enjoyed the FDA approval of two agents for treatment of diabetic peripheral neuropathic pain (duloxetine [Cymbalta], pregabalin [Lyrica]), as yet we have no treatment for diabetic peripheral neuropathy itself.
-
Administration of sterile viable Trichuris suis eggs to patients with active Crohns disease led to impressive clinical improvement.
-
In selected patients with community-acquired pneumonia, outpatient treatment with levofloxacin was as safe and effective as hospitalization.
-
Solifenacin succinate has been approved for the treatment of overactive bladder, the third new agent to be approved for this indication in the last 7 months.
-
The lead II rhythm strip shown in the Figure was taken from a patient in atrial flutter. Although difficult to see due to artifact in the baseline, an underlying sawtooth pattern is nevertheless present. In addition, there is something distinctly unusual about this example of atrial flutter. What is it? What clinical diagnosis is suggested as a possible cause of this ECG finding?
-
Stopping aspirin may be hazardous to your health, according to recent research.
-
A standardized work-up will reveal a cause for drop attacks, which are sudden collapse without loss of consciousness, in 90% of cases.
-
Contradicting previous studies, no evidence was found in a large review of cancer patients that deaths were postponed relative to significant life events.
-
Clinicians share a common goal in respect to early diagnosis and treatment of colon cancer, yet the optimum pathway with which to reach this goal is controversial.
